Literature DB >> 20433679

Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial.

Silvia Govi, Giuseppina P Dognini, Giada Licata, Roberto Crocchiolo, Antonio Giordano Resti, Maurilio Ponzoni, Andrés J M Ferreri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20433679     DOI： 10.1111/j.1365-2141.2010.08179.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  25 in total

1.  A case of follicular B-cell lymphoma treated using clarithromycin.

Authors:  Masashi Ohe; Satoshi Hashino
Journal:  Korean J Hematol       Date:  2011-09-30

2.  [Clarithromycin for monotherapy of B-cell MALT lymphoma?].

Authors:  C Auw-Hädrich; J Finke; A Serr; H Mittelviefhaus; C Bogdan; T Reinhard
Journal:  Ophthalmologe       Date:  2013-11       Impact factor: 1.059

Review 3.  Chemoimmunotherapy for Mucosa-Associated Lymphoid Tissue-Type Lymphoma: A Review of the Literature.

Authors:  Barbara Kiesewetter; Andrés J M Ferreri; Markus Raderer
Journal:  Oncologist       Date:  2015-07-08

Review 4.  Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.

Authors:  Naoki Asano; Katsunori Iijima; Tomoyuki Koike; Akira Imatani; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

Review 5.  Recent developments in nongastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Marlene Troch; Barbara Kiesewetter; Markus Raderer
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

Review 6.  Conjunctival Lymphoma.

Authors:  Lindsay A McGrath; David A Ryan; Sunil K Warrier; Sarah E Coupland; William J Glasson
Journal:  Eye (Lond)       Date:  2022-07-26       Impact factor: 4.456

7.  [Clarithromycin therapy of a B cell MALT lymphoma].

Authors:  L Danilko; K Haas; U Schönherr; G Tschurtschenthaler
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

8.  Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide.

Authors:  Masashi Ohe; Satoshi Hashino
Journal:  Korean J Intern Med       Date:  2013-05-01       Impact factor: 2.884

9.  Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells.

Authors:  Seiichiro Komatsu; Keisuke Miyazawa; Shota Moriya; Akiko Takase; Munekazu Naito; Masato Inazu; Norio Kohno; Masahiro Itoh; Akio Tomoda
Journal:  Int J Oncol       Date:  2011-12-23       Impact factor: 5.650

10.  Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone.

Authors:  Masashi Ohe; Satoshi Hashino; Atsuo Hattori
Journal:  Korean J Hematol       Date:  2012-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.